Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - TOTAL OTHER INCOME
Total Other Income IKT - Inhibikase Therapeutics, Inc.
1.07 M
LAST VALUE
278.95%
2 YEAR CAGR
114.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR